TH174927A - Nutritional elements containing ceramides - Google Patents
Nutritional elements containing ceramidesInfo
- Publication number
- TH174927A TH174927A TH1601005027A TH1601005027A TH174927A TH 174927 A TH174927 A TH 174927A TH 1601005027 A TH1601005027 A TH 1601005027A TH 1601005027 A TH1601005027 A TH 1601005027A TH 174927 A TH174927 A TH 174927A
- Authority
- TH
- Thailand
- Prior art keywords
- galactose
- ceramides
- plant
- nutritional
- cholesterol
- Prior art date
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract 7
- 229940106189 Ceramides Drugs 0.000 title abstract 5
- 150000001783 ceramides Chemical class 0.000 title abstract 5
- VODZWWMEJITOND-OWWNRXNESA-N N-Stearoylsphingosine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)\C=C\CCCCCCCCCCCCC VODZWWMEJITOND-OWWNRXNESA-N 0.000 claims abstract 3
- 102000004169 proteins and genes Human genes 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 abstract 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 4
- 229940107161 Cholesterol Drugs 0.000 abstract 2
- 235000012000 cholesterol Nutrition 0.000 abstract 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 abstract 2
- 210000004556 Brain Anatomy 0.000 abstract 1
- 208000010201 Exanthema Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010037844 Rash Diseases 0.000 abstract 1
- 230000002009 allergen Effects 0.000 abstract 1
- 230000000295 complement Effects 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 238000011109 contamination Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002708 enhancing Effects 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 231100000046 skin rash Toxicity 0.000 abstract 1
Abstract
คำขอใหม่ปรับปรุง การเปิดเผยนี้เกี่ยวข้องกับองค์ประกอบทางโภชนาการซึ่งรวมถึงเซราไมด์อย่างน้อยที่สุดหนึ่ง ชนิด องค์ประกอบทางโภชนาการอาจรวมเพิ่มเติมถึงกาแลกโตส, กรดเซียลิก, หรือคอลเลสเตอรอล อาจจัดให้มีเซราไมด์และกาแลกโตสโดยแหล่งซึ่งมีพื้นฐานจากพืช องค์ประกอบทางโภชนาการ ซึ่งรวมถึงเซราไมด์และกาแลกโตสจากแหล่งซึ่งมีพื้นฐานจากพืชอาจลดความเสี่ยงของการปนเปื้อน ข้ามขององค์ประกอบทางโภชนาการที่มีสารก่อการแพ้โปรตีนซึ่งมีพื้นฐานจากสัตว์ เซราไมด์ซึ่งมี พื้นฐานจากพืชและกาแลกโตสเหล่านี้อาจทำให้เกิดผลทางสุขภาพที่เป็นประโยชน์เพิ่มหรือเสริมกัน เมื่อบริโภค การเปิดเผยเกี่ยวข้องเพิ่มเติมกับวิธีการลดอุบัติการณ์ของผื่นผิวหนังซึ่งสาเหตุโดยการแพ้ หรือการเพิ่มสุขภาพทางสมองและตาในบุคคลที่เป็นเป้าหมายโดยการจัดให้องค์ประกอบทาง โภชนาการซึ่งประกอบรวมด้วยเซราไมด์, กาแลกโตส, กรดเซียลิก, และคลอเรสเตอรอลแก่บุคคล ที่เป็นเป้าหมาย New requests, improvements This disclosure relates to the nutritional composition, which includes at least one type of ceramide.Nutritional constituents may include additional galactose, sialic acid, or cholesterol. Ceramides and galactose may be provided by a plant-based source. Nutritional composition These include ceramides and galactose from plant-based sources may reduce the risk of contamination. Cross of nutritional elements containing protein allergens, which are based on animals. Ceramides which contain These plant-based and galactose bases may cause additional or complementary health effects when consumed.Further disclosure involves methods of reducing the incidence of skin rashes caused by allergies. Or enhancing brain and eye health in targeted individuals by providing Nutrition, which contains ceramides, galactose, sialic acid, and cholesterol to individuals. That is the goal
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH174927A true TH174927A (en) | 2018-03-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023005755A (en) | Compostion comprising siallyllactose for use in enhancing learning skills and memory function. | |
| BR112017024928A2 (en) | METHODS FOR PREVENTING DIABETES OR PRE-DIABETES IN AN INDIVIDUAL, FOR IMPROVING THE RESPONSE TO GLUCOSE IN AN INDIVIDUAL WITH GLUCOSE INTOLERANCE, FOR MAINTAINING THE RESPONSE TO GLUCOSE IN AN INDIVIDUAL WITH GLUCOSE TOLERANCE, AND TO IMPROVEMENT OF THE GLUCOSE AND TO IMPROVEMENT OF THE GLUCOSE, AND TO IMPROVEMENT OF THE GLUCOSIS PROBIOTICS AND PHARMACEUTICAL COMPOSITION | |
| PH12015501751A1 (en) | Nutritional compositions containing an enriched lipid fraction and uses thereof | |
| BR112014008511A2 (en) | phytonutrient nutritional compositions | |
| SG10201909093XA (en) | Mixed allergen compositions and methods for using the same | |
| PH12016500026A1 (en) | Nutritional compositions containing synergistic combination and uses thereof | |
| EA201070419A1 (en) | COMPOSITION FOR REGULATING METABOLISM OF LIPIDS | |
| PH12017502181A1 (en) | Nutritional compositions containing an elevated level of inositol and uses thereof | |
| PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| MX2018004715A (en) | Composition comprising a mixture of molecules extracted from chrysanthellum indicum, cynara scolymus and lycium barbarum and use to act on carbohydrate and/or fat metabolism. | |
| AR106624A1 (en) | NUTRITIONAL COMPOSITIONS CONTAINING DIETARY BUTIRATE AND USES OF THE SAME | |
| PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| PH12018500036A1 (en) | Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid | |
| PH12016501952A1 (en) | Nutritional compositions directed to subjects having cow`s milk protein allergies | |
| BR112018008040A2 (en) | nutritional composition comprising a casein hydrolyzate as well as a dietary butyrate and / or a compound for stimulating the formation of endogenous butyrate | |
| AR096942A1 (en) | METHODS TO PROMOTE NEURONAL DEVELOPMENT AND / OR HEALTH | |
| TH174927A (en) | Nutritional elements containing ceramides | |
| PH12016501390A1 (en) | Nutritional compositions containing ceramide | |
| PH12015500530A1 (en) | Beta-hydroxy-beta-methylbutryic acid-containing compositions and uses thereof | |
| TH178071A (en) | Nutritional components with higher lipids and their use | |
| TH14365A3 (en) | Mousse added with whey protein, dietary fiber, choline and collagen, the formula for reducing saturated fat, cholesterol and sugar. | |
| TH14365C3 (en) | Mousse with whey protein, dietary fiber, choline and collagen, saturated fat, cholesterol and sugar reduction formula. | |
| TH149860A (en) | Casein - partially hydrolyzed whey to reduce the onset of allergies | |
| LV15463A (en) | 3-quinoline carboxilic acid-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-4-(2-thienyl) esters as the free fatty acid family ffar3 receptor selective ligands and syntons for creating new ligands | |
| WO2017037539A3 (en) | Modulation of the phospholipase a2-activating protein for treatment of myelin related diseases |